Literature DB >> 1696097

Production of circulation interferon in children with varicella.

H Takamiya1, N Maehara, T Nakayama, K Takekuma, H Kawashima, T Honda, S Makino, M Matumoto.   

Abstract

Interferon (IFN) alpha was detected in the serum of children with varicella. The serum IFN was demonstrated in the acute phase of varicella and became negative 7 days after the onset of rash. Serum IFN was detected during the incubation period in two patients tested before the onset of rash. Some correlation was shown between the positive rate of circulating IFN and the severity of illness.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1696097     DOI: 10.1007/bf01323167

Source DB:  PubMed          Journal:  Arch Virol        ISSN: 0304-8608            Impact factor:   2.574


  8 in total

1.  INTERFERON IN DERMAL CRUSTS OF HUMAN VACCINIA VIRUS VACCINATIONS POSSIBLE EXPLANATION OF RELATIVE BENIGNITY OF VARIOLATION SMALLPOX.

Authors:  E F WHEELOCK
Journal:  Proc Soc Exp Biol Med       Date:  1964-12

2.  CIRCULATING INTERFERON AFTER MEASLES VACCINATION.

Authors:  J K PETRALLI; T C MERIGAN; J R WILBUR
Journal:  N Engl J Med       Date:  1965-07-22       Impact factor: 91.245

3.  CIRCULATING VIRUS, INTERFERON AND ANTIBODY AFTER VACCINATION WITH THE 17-D STRAIN OF YELLOW-FEVER VIRUS.

Authors:  E F WHEELOCK; W A SIBLEY
Journal:  N Engl J Med       Date:  1965-07-22       Impact factor: 91.245

4.  A VIRUS INHIBITOR IN PHARYNGEAL WASHINGS FROM PATIENTS WITH INFLUENZA.

Authors:  I GRESSER; H B DULL
Journal:  Proc Soc Exp Biol Med       Date:  1964-01

5.  ACTION OF ENDOGENOUS INTERFERON AGAINST VACCINIA INFECTION IN CHILDREN.

Authors:  J K PETRALLI; T C MERIGAN; J R WILBUR
Journal:  Lancet       Date:  1965-08-28       Impact factor: 79.321

6.  Semi-micro, dye-binding assay for rabbit interferon.

Authors:  J A Armstrong
Journal:  Appl Microbiol       Date:  1971-04

7.  Clinical studies on interferon. I. Interferon production in children with viral diseases.

Authors:  T Kozaki
Journal:  Nagoya J Med Sci       Date:  1969-07       Impact factor: 1.131

8.  Early immune response in healthy and immunocompromised subjects with primary varicella-zoster virus infection.

Authors:  A M Arvin; C M Koropchak; B R Williams; F C Grumet; S K Foung
Journal:  J Infect Dis       Date:  1986-09       Impact factor: 5.226

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.